Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes

ML Belladonna, P Puccetti, C Orabona… - …, 2007 - journals.lww.com
ML Belladonna, P Puccetti, C Orabona, F Fallarino, C Vacca, C Volpi, S Gizzi, MT Pallotta…
Transplantation, 2007journals.lww.com
Tryptophan catabolism occurring in dendritic cells (DCs) and initiated by indoleamine 2, 3-
dioxygenase (IDO) is an emerging major mechanism of peripheral tolerance. Here we
provide evidence that: 1) tryptophan conversion to kynurenines is activated in DCs by
cytotoxic T lymphocyte antigen 4, both in a soluble form or anchored to the regulatory T cell
(T reg) membrane; 2) an increased IDO-dependent tolerogenesis correlates with the
inhibition of DAP12 functions, an adapter molecule associated with activating receptors; 3) a …
Abstract
Tryptophan catabolism occurring in dendritic cells (DCs) and initiated by indoleamine 2, 3-dioxygenase (IDO) is an emerging major mechanism of peripheral tolerance. Here we provide evidence that: 1) tryptophan conversion to kynurenines is activated in DCs by cytotoxic T lymphocyte antigen 4, both in a soluble form or anchored to the regulatory T cell (T reg) membrane; 2) an increased IDO-dependent tolerogenesis correlates with the inhibition of DAP12 functions, an adapter molecule associated with activating receptors; 3) a tolerogenic phenotype can be acquired by DCs lacking functional IDO through the paracrine production of kynurenines by IDO-competent DCs; 4) the suppressive effect of T reg generated in a microenvironment with low tryptophan concentration and a mixture of kynurenines can protect mice in an experimental model of fulminant diabetes. Altogether, these data indicate that, in addition to tryptophan starvation induced by IDO activity, the paracrine production of kynurenines by enzymes downstream of IDO can also contribute to tolerogenesis in DCs, independently of tryptophan deprivation.
Lippincott Williams & Wilkins